Larimar Therapeutics (LRMR) Non-Current Debt (2016 - 2020)
Historic Non-Current Debt for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to $6.7 million.
- Larimar Therapeutics' Non-Current Debt fell 5011.83% to $6.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was $6.7 million, marking a year-over-year decrease of 5011.83%. This contributed to the annual value of $8.5 million for FY2019, which is 4426.08% down from last year.
- Per Larimar Therapeutics' latest filing, its Non-Current Debt stood at $6.7 million for Q1 2020, which was down 5011.83% from $8.5 million recorded in Q4 2019.
- Larimar Therapeutics' Non-Current Debt's 5-year high stood at $20.2 million during Q1 2018, with a 5-year trough of $1.2 million in Q3 2016.
- Over the past 5 years, Larimar Therapeutics' median Non-Current Debt value was $11.9 million (recorded in 2019), while the average stood at $11.3 million.
- As far as peak fluctuations go, Larimar Therapeutics' Non-Current Debt plummeted by 7116.77% in 2016, and later crashed by 2407.5% in 2018.
- Quarter analysis of 5 years shows Larimar Therapeutics' Non-Current Debt stood at $1.2 million in 2016, then soared by 1566.67% to $20.0 million in 2017, then dropped by 24.08% to $15.2 million in 2018, then crashed by 44.26% to $8.5 million in 2019, then fell by 20.29% to $6.7 million in 2020.
- Its Non-Current Debt was $6.7 million in Q1 2020, compared to $8.5 million in Q4 2019 and $10.2 million in Q3 2019.